Skip to main content
. 2020 Apr 30;6(2):35. doi: 10.3390/ijns6020035

Figure 1.

Figure 1

Elapsed Time from First Programmatic Activity to Implementation of Statewide Newborn Screening for Pompe, Mucopolysaccharidosis type I (MPS I), and adrenoleukodystrophy (ALD) using Kaplan–Meier Survival Analysis, as of August 2019. Programs without a recorded date of implementation by 1 August 2019 were considered censored.